SCHEMBL29092217

SCHEMBL29092217

COc1ccc(Cl)c(-c2ccnc(N)c2N)c1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ HSP90AA1 P07900 3/20 0.50
▸ HSP90AB1 P08238 2/20 0.50
▸ SCN10A Q9Y5Y9 3/20 0.45
▸ NOS3 P29474 2/20 0.45
▸ NOS2 P35228 2/20 0.45
▸ NOS1 P29475 1/20 0.45
▸ CCNT1 O60563 3/20 0.43
▸ CDK9 P50750 3/20 0.43
▸ KDM1A O60341 1/20 0.43
▸ SCN1A P35498 1/20 0.42
▸ SCN5A Q14524 1/20 0.42
▸ SCN9A Q15858 1/20 0.42
▸ DYRK1A Q13627 4/20 0.40
▸ CCR1 P32246 1/20 0.40
▸ CCR5 P51681 1/20 0.40
▸ CCR8 P51685 1/20 0.40
▸ CDC37 Q16543 1/20 0.38
▸ NPC1 O15118 1/20 0.37
▸ CDC7 O00311 1/20 0.37
▸ CSNK2A2 P19784 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19785375 0.78 HSP90AA1 (0.56) HSP90AA1HSP90AB1SCN10AKDM1A
SCHEMBL1823930 0.76 DYRK1A (0.53) NOS3NOS2NOS1DYRK1ANPC1
SCHEMBL1165314 0.74 FYN (0.52) NOS3NOS2NOS1DYRK1ACCR1
SCHEMBL263442 0.74 SCN10A (0.58) HSP90AA1HSP90AB1SCN10ANOS3NOS2
SCHEMBL4938505 0.74 DYRK1A (0.54) NOS3NOS2NOS1DYRK1AGSK3B
SCHEMBL3723167 0.73 HSP90AA1 (0.47) HSP90AA1HSP90AB1SCN10AKDM1ASCN1A
SCHEMBL4017565 0.72 NR1H2 (0.47) HSP90AA1HSP90AB1CCNT1CDK9KDM1A
SCHEMBL13505855 0.72 LIMK1 (0.45) HSP90AA1HSP90AB1NOS3NOS2NOS1
SCHEMBL21187454 0.72 HSP90AA1 (0.49) HSP90AA1HSP90AB1SCN10ANOS3NOS2
SCHEMBL15751000 0.71 HSP90AA1 (0.51) HSP90AA1HSP90AB1SCN10AKDM1ANPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-111868037-B Fused cyclic urea derivatives as CRHR2 antagonists 拉夸里亚创药株式会社 2023-10-13 — — CN disclosed
Send feedback